Read our latest updates from research breakthroughs to government actions to fundraising heroes. You can also read personal stories from women and their families directly affected by ovarian cancer.
Stephen recently did a skydive in memory of his sister, who passed away earlier this year with ovarian cancer. He talks about his fundraising experience and why it was important to him to raise awareness along the way...
Jennifer and her friend Lynsey ran a unique marathon this September, around the infamous Loch Ness. She tells us all about their training, motivation and why they’ve fundraised in memory of Gillian.
Target Ovarian Cancer has found that as many as one in every five women (20 per cent) in England is too ill to treat by the time they receive their ovarian cancer diagnosis, according to data released this week.
Target Ovarian Cancer's new project represents a new frontier in ovarian cancer research.
This time last year, we launched our ‘It’s time to TAKE OVAR’ campaign. The campaign aims to transform the futures of more than 25,000 women in the UK who are living with ovarian cancer – and thousands more who are yet to be diagnosed.
Today, the National Institute for Health and Care Excellence (NICE) has published some draft guidance about ovarian cancer drug olaparib (Lynparza®).
Sign up to receive emails from Target Ovarian Cancer, including our monthly newsletter, and be the first to hear about campaigns, upcoming events and fundraising inspiration.
Sign up
